Close Menu

NEW YORK — Creoptix, a Swiss developer of optical bioanalytic instrumentation, said today that it has raised CHF 8 million ($8.0 million) in a Series C financing round.

The round was led by Zürcher Kantonalbank's Swisscanto Invest and included existing investor Waters. In connection with the round, Swisscanto Invest has received a seat on Creoptix's board of directors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York City Police Department will be removing DNA profiles from a local database if they are from people who were never convicted of a crime, the New York Times reports.

Science reports that accusations of sexual assault against a microbiome researcher has also led to questions about his academic certifications.

Wired reports that researchers are analyzing the DNA fish leave behind in water to study their populations.

In Science this week: comprehensive cellular map of the human thymus, evidence of admixture between the ancestors of Neanderthals and Denisovan and a 'superarchaic' population.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.